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Abstract
Background: Several animal species can reportedly act as reservoirs for Hepatitis E virus (HEV),
a zoonotic pathogen. HEV and antibody to the virus have been detected in a variety of animals
including rodents. Pig and rat models for HEV have been established for HEV, but a nude mouse
has not yet been developed.
Methods: Balb/c nude mice were inoculated with swine HEV, both orally and via intravenous
injection to insure infection. Negative control and experimental contact-exposed groups of mice
were also included in the study. The liver, spleen, kidney, jejunum, ileum, cecum and colon of each
mouse from all three groups were collected for reverse transcription nested polymerase chain
reaction (RT-nPCR) detection, indirect immunofluorescence observation and histopathologic
examination. The sera from nude mice were tested for anti-HEV IgG by enzyme linked
immunosorbent assay (ELISA). Activities of liver enzymes, including alanine aminotransferase
(ALT), aspartate aminotransferase (AST) and alkaline phosphatase (ALP), as well as total bilirubin
(TBIL) were also measured in the sera of the nude mice.
Results: HEV antigens and HEV RNA were detected in liver, spleen, kidney, jejunum, ileum and
colon both by indirect immunofluorescence and by RT-nPCR in all of the inoculated and in one of
the contact-exposed nude mice. Histopathological changes were observed in the liver and spleen
of these mice. Infected mice showed increased levels of AST, ALP, and anti-HEV IgG in sera. The
livers of contact-exposed mice showed obvious histopathological damage.
Conclusion: Nude mice could be readily infected by HEV isolated from pigs. The nude mouse may
therefore be a useful animal model for studying the pathogenesis of HEV.
Background
Hepatitis E (HE) is an acute self-limiting disease in adults
that has particularly high mortality in pregnant women.
The causative agent of HE, the HEV, is a zoonotic patho-
gen that is transmitted primarily by a fecal-oral route
[1,2]. HEV shows cross-species transmission in pigs,
chickens, rats, deer, cats and cattle [3-8]. Rodents are con-
sidered to be a potential reservoir of HEV because anti-
HEV antibodies are widespread in both domestic and wild
rats [9-13].
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Some unsubstantiated evidence has even suggested that
domestic rats may have been the original source of human
HEV infection [11]. HEV has the ability to cross species
barriers, causing infections between nonhuman primates
and swine [14-19]. Therefore, from a human health stand-
point, it is important to identify whether cross-species
transmission is possible between swine and rodents.
Hepatitis E has widely been paid attention for antibody
now found globally in the human population [7,20-22].
In developing countries, it is one of the most important
causes of acute clinical hepatitis in adults [7]. Although
cell culture systems for propagating hepatitis E have been
developed [23-25], the availability of laboratory animal
models is still of critical importance for studying HEV
pathogenicity. The establishment of a nude mouse model
for HEV infection could therefore possibly circumvent
these issues. It would also have the added benefit of per-
mitting the study of the molecular mechanisms of cross-
species transmission, as well as the evaluation of vaccines.
The aim of the present study was therefore to establish a
HEV infection model in nude mice to aid in identifying
the essential HEV transmission routes in this animal.
Methods
Animals
Twelve 5-week-old, 18~22 g specific-pathogen-free (SPF)
male Balb/c nude mice were purchased from the National
Rodent Laboratory Animal Resources, Shanghai Branch
(China) and maintained in a pathogen-free animal facil-
ity. The study protocol was approved by Animal Care and
Use Committee (ACUC) of Shanghai Research Center for
Biomodel Organisms. We followed guidelines of the
Shanghai Research Center for Biomodel Organisms dur-
ing this study. All nude mice were tested for anti-HEV IgG
by ELISA (KHB, Shanghai, China). Nude mice confirmed
seronegative for HEV infection by ELISA were included in
the study.
Virus
The swine HEV for inoculation, characterized as genotype
IV [GenBank: EF570133], was isolated from swine feces
from the Shanghai area, China. The HEV RNA was
detected by RT-nPCR [26,27]. Positive feces were sus-
pended in phosphate-buffered saline (PBS), pH 7.4 with
0.01% diethyl pyrocarbonate (DEPC), at a proportion of
10% (w/v). The suspension was centrifuged at 12000 × g
for 10 min, followed by filtration through 0.22 μm micro-
filters before inoculation. Virus was inoculated into each
nude mouse at a minimum viral count of 1–2 × 105/ml of
feces supernatant, as calculated by viral genomic titer
determined by Real-Time quantitative PCR [28,29].
Experimental Design
Twelve SPF nude mice were randomly divided into three
groups, four nude mice per group. Group No. 1 was the
negative control intravenously inoculated with 0.25 ml
sterilized PBS; Group No.2 was inoculated with swine
HEV (0.25 ml intravenously and also 0.25 ml orally [29]);
Group No.3 was used for experimental contact-exposure
infection and consisted of three uninoculated SPF nude
mice cohabiting with one inoculated nude mouse from
Group No.2. Feces were collected daily post-inoculation.
Each nude mouse was humanely euthanized, at either 4,
7, 14 or 21 days post-inoculation following the guidelines
of the Care and Use of Laboratory Animals. Blood was col-
lected for RT-nPCR detection, ELISA tests and enzyme
activity assays. Liver, spleen, kidney, jejunum, ileum,
cecum, and colon were collected, and each tissue was
divided into three portions for RT-nPCR detection, indi-
rect immunofluorescence observation and histopatho-
logic examination, respectively. Two portions were stored
at -80°C until use, while the third portion was fixed in
10% neutral buffered formalin for histopathologic exam-
ination immediately upon sampling.
ELISA determination
HEV IgG was determined using a commercial ELISA kit
(KHB, Shanghai, China) based on recombinant HEV
fusion proteins according to the manufacturer's direc-
tions. The kit used recombinant HEV fusion proteins
derived from the putative structural proteins of HEV as
primary antibody, and contained both positive and nega-
tive controls. The cutoff values for the IgG assay were
determined based on 0.22 plus the mean OD450 values of
sera from uninfected nude mice (± standard deviation).
Serum liver chemistry profile
The activities of ALT, AST, ALP and levels of TBIL in sera
were measured with an automated biochemistry analyzer
(Olympus 2700, Japan).
RT-PCR detection
Total RNA was extracted from all specimens by Trizol
(Invitrogen, America), according to the manufacturer's
instructions. Reverse transcription was performed using
an AMV Reverse Transcriptase XL for RT-PCR (Takara,
Japan) according to the manufacturer's directions. HEV-
specific primers have been previously described [26]; the
external primers were forward primer (P1): 5'-AATTAT-
GCC(T)CAGTAC(T)CGG(A)GTTG-3' and reverse primer
(P2): 5'-CCCTTA(G)TCC(T)TGCTGA(C)GCATTCTC-3',
and the internal primers were forward primer (P3): 5'-
GTT(A)ATGCTT(C)TGCATA(T)CATGGCT-3' and reverse
primer (P4): 5'-AGCCGACGAAATCAATTCTGTC-3'. The
product of RT-nPCR was expected to be 348 base pairs.
The RT-PCR protocol was performed at 30°C for 10 min,
42°C for 30 min, 99°C for 5 min and 5°C for 5 min. TheBMC Infectious Diseases 2009, 9:93 http://www.biomedcentral.com/1471-2334/9/93
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resulting cDNA was amplified by nested PCR at 94°C for
2 min, followed by 94°C for 30 sec, 42°C for 30 sec and
72°C for 1 min, and repeated for 29 cycles. The PCR prod-
ucts were detected by electrophoresis on agarose gel con-
taining 0.5 μg/ml ethidium bromide.
Indirect immunofluorescence observation
Frozen tissues were cut at a thickness of 6 μm for indirect
immunofluorescence observation. HEV-specific ORF2
primary antibody (ABR, America, 1:500 dilution),
designed to detect capsid proteins of HEV genotypes (1–
4), was added to sections and incubated at 37°C for 30
min. After washing with PBS, FITC-labelled goat anti-
mouse secondary antibody (Dingguo, China, 1:500 dilu-
tion) was added and incubated at 37°C for 30 min. After
washing with PBS, slides were observed with a Nikon
TE2000 fluorescence microscope (Japan). All specimens
were tested in duplicate with positive control (specimens
of HEV infected rat) and negative control (specimens of
uninfected nude mice).
Histopathologic examination
Tissues for histologic examination were fixed in 10% neu-
tral buffered formalin, routinely processed, sectioned at a
thickness of 7 μm, and stained with hematoxylin and
eosin. The tissue sections were examined and compared
with negative controls.
Results
Clinical evaluation
Evidence of clinical disease, such as acute hepatitis with
icteric viral hepatitis or diarrhea in humans, was not
found in any of the experimental groups.
Detection of HEV RNA by RT-nPCR
HEV RNA was detected by RT-nPCR, beginning four days
after inoculation in feces from all inoculated nude mice.
In livers, spleens, kidneys, jejunums, ileums and colons,
RNA was detected 4, 7 and 14 days post-inoculation, and
in sera on days 4 and 7 post-inoculation. HEV RNA was
detected in the feces of only one of the contact-exposed
mice from day 7 to 20 post-inoculation, but was found in
liver, spleen, kidney and sera sampled on day 14. How-
ever, HEV RNA was not detected in any of the tissues, sera
or feces in the negative controls.
ELISA determination
An increased anti-HEV IgG was seen in all inoculated mice
compared with the negative control group. Although IgG
was also elevated in the contact-exposured group, but the
increase was slower to appear and lower in magnitude
than that seen in the inoculated group. All assays were
performed in triplicate and data are expressed as means (±
standard deviation). The mean values of OD450 for the
three groups were analyzed by SAS System software [Fig-
ure 1].
Liver enzyme profile
Liver enzyme activities were characterized using an auto-
mated biochemistry analyzer. There were no significant
differences in the levels of TBIL or ALT among the three
groups. The level of AST was increased (about 2.6 fold) in
the inoculated group (No.2) and moderately increased in
contact-exposed group (No.3) compared with the nega-
tive control group (No.1). The level of ALP was increased
in both the inoculated group (No.2) and the contact-
exposed group (No.3) [Figure 2A]. All procedures were
performed in triplicate and data are expressed as means (±
Anti-HEV IgG in nude mice as determined by ELISA Figure 1
Anti-HEV IgG in nude mice as determined by ELISA. Anti-HEV IgG was significantly elevated in the inoculated group 
(No.2, pink line) but increases were slower to appear in the contact-exposed group (No.3, yellow line). No changes were seen 
in the negative control group (No.1, dark line). The cutoff is 0.22+ the mean values of the negative control (blue line).
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Changes in enzyme activities for AST, ALP, ALT and in levels of TBIL Figure 2
Changes in enzyme activities for AST, ALP, ALT and in levels of TBIL. A: The levels of AST, ALP, ALT activities and 
TBIL in the uninoculated group, the inoculated group and the contact-exposed group 7 days post-inoculation. The data repre-
sent the average of three experiments, with the standard deviation indicated by error bars. B: Enzyme activity changes in nude 
mouse in three groups.BMC Infectious Diseases 2009, 9:93 http://www.biomedcentral.com/1471-2334/9/93
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S.D.). The changes in the three enzyme activities and in
bilirubin levels (AST, ALT, ALP, and TBIL) among three
groups are shown in [Figure 2B].
Indirect immunofluorescence
HEV antigens were observed by indirect immunofluores-
cence in liver, spleen, kidney, jejunum, ileum and colon
in the inoculated group on days 4 and 7, and in one of
member of contact-exposed group on day 7 using appro-
priate controls [Figure 3A–F]. HEV antigen was consist-
ently detected in the cytoplasm [Figure 3A], splenocytes
[Figure 3B] and renal cells [Figure 3C], and interspersed in
jejunum [Figure 3D], ileum [Figure 3E] and colon [Figure
3F] in all the inoculated mice and in one of the contact-
exposed mice. The HEV antigen was abundant in the liver
and especially in the spleen. We also identified several
potential HEV replication sites in jejunum, ileum and
colon that have not been reported in nude mice prior to
this study. As we expected, one of the contact-exposed
mice showed HEV antigens in spleen, liver, and colon,
which is consistent with previous studies following con-
tact exposure transmission [11,13,30]. We found no sig-
nal in any of the negative control tissues [Figure 3H].
Histopathologic examination
Histopathologic examination of the livers showed
enlargement in one of inoculated mice, with liver capsules
filled with inflammatory exudates and liver hemorrhage
[Figure 4-A-1]. Hepatic inflammation, focal hepatocelluar
necrosis and liver hemorrhage were observed in all inocu-
lated mice, as well as in the contact-exposed group [Figure
4-A-2]. The hepatic lesions were mild in contact-exposed
mice but severe in the inoculated ones. Lymphocytic,
necrotic and cellular debris was observed in the spleens of
inoculated mice and in milder form in contact-exposed
mice [Figure 4-A-3]. Increased expression of infiltrating
lymphocytes and macrophages in renal cells were
observed [Figure 4-A-4]. No damage was observed in any
HEV antigen distribution in tissues of inoculated nude mice detected by indirect immunofluorescence 4d post-inoculation Figure 3
HEV antigen distribution in tissues of inoculated nude mice detected by indirect immunofluorescence 4d post-
inoculation. A: liver, granular fluorescence of HEV antigens distributed throughout hepatocytes, × 200; B: spleen, distinct 
granular fluorescence of HEV antigens distributed throughout the cytoplasm, especially around the venous sinus, × 100; C: kid-
ney, dozens of HEV antigens surrounding a renal cell, × 200; D: jejunum, distinct granular fluorescence of HEV antigens distrib-
uted in the epithelial cells, × 200; E: ileum, granular fluorescence of HEV antigens distributed in the ileum, × 200; F: colon, 
distinct granular fluorescence of HEV antigens distributed throughout colon, × 100; G: positive control, liver of HEV infected 
rat, × 100; H: negative control, liver of a nude mouse from the negative control group, × 200.
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of the negative control tissues [Figure 4-B 5 to 4-B 8]. The
biochemical, histologic, virologic and serologic changes
caused by HEV inoculation and/or contact exposure is
briefly summarized in Table 1.
Discussion
The results presented here strongly suggest that nude mice
are susceptible to swine HEV as evidenced by viral antigen
expression in liver and other extra-hepatic tissues, fecal
viral shedding, hepatic lesions, and the presence of anti-
HEV antibodies. The inoculated mice showed no clinical
signs of HEV infection, as has been previously reported for
other animal models, such as pigs and rats
[14,10,31,11,18]. These findings reported here are helpful
for the study of the replication mechanism, transmission
and pathogenesis of HEV.
We first detected HEV RNA in the feces 4 days post-inocu-
lation in agreement with previous findings in rats (4 day)
[11], cynomolgus macaques (4–6 day) [14] and pigs (7
day) [32]. In one of the contact-exposed nude mice, HEV
RNA was first detected 7 days post-inoculation; i.e., 3 days
later than in the directly inoculated mice. This delay
reflected the lag time for virus to appear in the feces of the
cohabiting inoculated mouse, and indicates that contact
exposure infection occurred primarily by a fecal-oral
route. In the liver, spleen, kidney, and colon of inoculated
mice, HEV RNA was detected by RT-nPCR on day 4, 7, and
14, and HEV antigens were observed by indirect immun-
ofluorescence. A large number of fluorescent of HEV anti-
gen were observed in liver, spleen, and kidney, indicating
these to be heavily infected tissues. Only a few suspected
fluorescent HEV antigens were seen in the jejunum, ileum
and colon [Figure 3]. This would indicate that HEV was
probably replicating in these tissues, which is consistent
with the previous studies [33], but this need to be further
demonstrated with in situ hybridization. We detected HEV
RNA in sera on day 4 and 7, but were unable to perform
daily serum collection. In nonhuman primates and swine,
the HEV RNA can be detected in bile [33], but it is not pos-
sible to obtain bile from a nude mouse owing to its small
body size.
HEV infection in rats has been shown to have some
aspects in common with HEV infection in nonhuman pri-
mates and swine; but one exception was that levels of ALT
liver enzymes did not become elevated [11]. In the current
study, ALT levels in nude mice were also unchanged by
HEV infection in nude mice. Aggarwal et al (2001) has
confirmed that ALT elevation may not a useful indicator
of HEV infection in primates [20]. In contrast, the level of
AST was significantly elevated in inoculated (2.6 fold) and
contact exposed nude mice (1.6 fold). In addition, the
sera of inoculated and contact exposed mice had elevated
ALP activities, but no increases in TBIL were seen in
response to HEV infection over the 21 days duration of
the study.
The presence of HEV in stool can serve as a major source
of transmission by contact exposure to other animals. In
the current study, one of the contact-exposed mice
became infected from viruses excreted by an inoculated
Table 1: Biochemical, histologic, virologic and serologic changes in response to experimental inoculation of nude mice with HEV
Group No.1 No.2 No.3
HEV-RNA (feces) 0d - - -
4d - +(4/4) -
7d - +(4/4) +(1/4)
14d - +(4/4) +(1/4)
21d - - -
Liver - +(4/4) +(1/4)
Spleen - +(4/4) +(1/4)
Kidney - +(4/4) +(1/4)
HEV-antigen Jejunum - +(4/4) -
Ileum - +(4/4) -
Colon - +(4/4) -
Anti-HEV IgG - +(4/4) +(1/4)
IHC - +(4/4) +(1/4)
ALT --- --- ---
AST --- ↑↑
ALP --- ↑↑
TBIL --- --- ---
Histologic change no change obvious obvious
-: HEV RNA negative detected by RT-PCR; +: HEV RNA positive detected by RT-PCR; IgG: the positive proportions of HEV antibodies detected by 
ELISA 21 days post-inoculation; IHC: the positive proportions of HEV antigen detected by indirect immunofluorescence; ---: no significant changes; 
↑: significantly elevated compared with a negative control.BMC Infectious Diseases 2009, 9:93 http://www.biomedcentral.com/1471-2334/9/93
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nude mouse. This contact-exposed mouse also showed
similar results to those shown by the inoculated nude
mice, except that the anti-HEV antibody response was
slower and AST liver enzyme levels were not as elevated.
These findings are in agreement with a previous report of
contact exposure in swine [13]. Taken together, the data
presented here show that HEV from swine can infect nude
mice and that this infection can readily occur through
fecal-oral transmission.
Conclusion
HEV replication mechanisms, cross-species transmission
and transmission by contact exposure could all be exam-
ined following experimental infection of Balb/c nude
mice with swine HEV. Therefore the nude mouse could be
considered as a promising animal model for HEV studies,
especially to evaluate candidate vaccines or antiviral treat-
ments.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
All authors participated in the planning of the project. XH
was the leader of the project. FH performed the nude mice
breeding and the main experiments. WZ, GG, CL, YJ car-
ried out the IIF and ELISA determinations together with
FH. SX collected all of the samples. All authors read and
approved the final manuscript.
Acknowledgements
This work was supported by Key Project of Shanghai Science and Technol-
ogy committee of China under Grant No.063919121.
References
1. Aggarwal R, Krawczynshi K: Hepatitis E: an overview and recent
advances in clinical and laboratory research.  J Gastroenterol
Hepatol 2000, 15:9-20.
2. Hsieh SY, Meng XJ, Wu YH, Liu ST, Tam AW, Lin DY, Liaw YF: Iden-
tity of a novel swine hepatitis E virus in Taiwan forming a
monophyletic group with Taiwan isolates of human hepatitis
E virus.  J Clin Microbiol 1999, 37:3828-3834.
3. Feagins AR, Opriessnig T, Huang YW, Halbur PG, Meng XJ: Cross-
species infection of specific-pathogen-free pigs by a genotype
4 strain of human hepatitis E virus.  J Med Virol 2008,
80:1379-1386.
4. Arankalle VA, Joshi MV, Kulkarni AM, Gandhe SS, Chobe LP, Raut-
mare SS, Mishra AC, Padbidri VS: Prevalence of anti-hepatitis E
virus antibodies in different Indian animal species.  J Viral Hepat
2001, 8:223-227.
Histopathologic changes in the inoculated group on day 21 Figure 4
Histopathologic changes in the inoculated group on day 21. A: 1, liver, one of the inoculated nude mice showed an 
enlarged liver filled with inflammatory exudates, × 200; 2, liver, severe lymphoplasmacytic and histiocytic hepatitis, focal accu-
mulation of inflammatory cells encircling hepatocytes, × 200; 3, spleen, the ruptured and enlarged spleen displaying multiple 
vacuolar degeneration and focal necrosis, × 200; 4, kidney, the disarranged kidney cells with increased lymphocytes and cellular 
debris, × 200 B: 5, negative control liver, × 200; 6, negative control liver, × 200; 7, negative control spleen, × 200; 8, negative 
control kidney, × 200. Tissues were stained with hematoxylin and eosin.
 Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Infectious Diseases 2009, 9:93 http://www.biomedcentral.com/1471-2334/9/93
Page 8 of 8
(page number not for citation purposes)
5. Huang FF, Sun ZF, Emerson SU, Purcell RH, Shivaprasad HL, Pierson
FW, Toth TE, Meng XJ: Determination and analysis of the com-
plete genomic sequence of avian hepatitis E virus (avian
HEV) and attempts to infect rhesus monkeys with avian
HEV.  J Gen Virol 2004, 85:1609-1618.
6. Okamoto H, Takahashi M, Nishizawa T, Usui R, Kobayashi E: Pres-
ence of antibodies to hepatitis E virus in Japanese pet cats.
Infection 2004, 32:57-58.
7. Tei S, Kitajima N, Takahashi K, Mishiro S: Zoonotic transmission
of hepatitis E virus from deer to human beings.  Lancet 2003,
362:371-373.
8. Vitral CL, Pinto MA, Lewis-Ximenez LL, Khudyakov YE, dos Santos
DR, Gaspar AM: Serological evidence of hepatitis E virus infec-
tion in different animal species from the Southeast of Brazil.
Mem Inst Oswaldo Cruz 2005, 100:117-122.
9. Hirano M, Ding X, Li TC, Takeda N, Kawabata H, Koizumi N, Kado-
saka T, Goto I, Masuzawa T, Nakamura M, Taira K, Kuroki T, Tan-
ikawa T, Watanabe H, Abe K: Evidence for widespread infection
of hepatitis E virus among wild rats in Japan.  Hepatol Res 2003,
27:1-5.
10. Kabrane-Lazizi Y, Fine JB, Elm J, Glass GE, Higa H, Diwan A, Gibbs CJ
Jr, Meng XJ, Emerson SU, Purcell RH: Evidence for widespread
infection of wild rats with hepatitis E virus in the United
States.  Am J Trop Med Hyg 1999, 61:331-335.
11. Maneerat Y, Clayson ET, Myint KS, Young GD, Innis BL: Experimen-
tal infection of the laboratory rat with the hepatitis E virus.
J Med Virol 1996, 48:121-128.
12. Purcell RH, Emerson SU: Animal models of hepatitis A and E.
ILAR J 2001, 42:161-177.
13. Bouwknegt M, Frankena K, Rutjes SA, Wellenberg GJ, de Roda Hus-
man AM, Poel WH van der, de Jong MC: Estimation of hepatitis E
virus transmission among pigs due to contact exposure.  Vet
Res 2008, 39:40.
14. Aggarwal R, Kamili S, Spelbring J, Krawczynski K: Experimental
studies on subclinical hepatitis E virus infection in cynomol-
gus macaques.  J Infect Dis 2001, 184:1380-1385.
15. Arankalle VA, Chobe LP, Chadha MS: Type-IV Indian swine HEV
infects rhesus monkeys.  J Viral Hepat 2006, 13:742-745.
16. McCaustland KA, Krawczynski K, Ebert JW, Balayan MS, Andjaparidze
AG, Spelbring JE, Cook EH, Humphrey C, Yarbough PO, Favorov
MO, Carson D, Bradley DW, Robertson BH: Hepatitis E virus
infection in chimpanzees: a retrospective analysis.  Arch Virol
2000, 145:1909-1918.
17. Meng XJ, Halbur PG, Shapiro MS, Govindarajan S, Bruna JD, Mush-
ahwar IK, Purcell RH, Emerson SU: Genetic and experimental
evidence of cross-species infection by the swine hepatitis E.
J Virol 1998, 72:9714-9721.
18. Purcall RH, Emerson SU: Hepatitis E: an emerging awareness of
an old disease.  J Hepatol 2008, 48:494-503.
19. Tsarev SA, Tsareva TS, Emerson SU, Yarbough PO, Legters LJ, Moskal
T, Purcell RH: Infectivity titration of a prototype strain of hep-
atitis E virus in cynomolgus monkeys.  J Med Virol 1994,
43:135-142.
20. Aggarwal R, McCaustland KA: Hepatitis E virus RNA detection
in serum and feces specimens with the use of microspin col-
umns.  J Virol Methods 1998, 74:209-213.
21. Meng XJ: Swine hepatitis E virus: cross-species infection and
risk in xenotransplantation.  Curr Top Microbiol Immunol 2003,
278:185-216.
22. Pei Y, Yoo D: Genetic characterization and sequence hetero-
geneity of a Canadian isolate of swine hepatitis E virus.  J Clin
Microbiol 2002, 40:4021-4029.
23. Tanaka T, Takahashi M, Kusano E, Okamoto H: Development and
evaluation of an efficient cell-culture system for Hepatitis E
virus.  J Gen Virol 2007, 88:903-911.
24. Takahashi M, Tanaka T, Azuma M, Kusano E, Aikawa T, Shibayama T,
Yazaki Y, Mizuo H, Inoue J, Okamoto H: Prolonged fecal shedding
of hepatitis E virus (HEV) during sporadic acute hepatitis E:
evaluation of infectivity of HEV in fecal specimens in a cell
culture system.  J Clin Microbiol 2007, 45:3671-3679.
25. Lorenzo FR, Tanaka T, Takahashi H, Ichiyama K, Hoshino Y, Yamada
K, Inoue J, Takahashi M, Okamoto H: Mutational events during
the primary propagation and consecutive passages of hepa-
titis E virus strain JE03-1760F in cell culture.  Virus Res 2008,
137:86-96.
26. Huang FF, Haqshenas G, Guenette DK, Halbur PG, Schommer SK,
Pierson FW, Toth TE, Meng XJ: Detection by reverse transcrip-
tion-PCR and genetic characterization of field isolates of
swine hepatitis E virus from pigs in different geographic
regions of the United States.  J Clin Microbiol 2002, 40:1326-1332.
27. Kasorndorkbua C, Halbur PG, Thomas PJ, Guenette DK, Toth TE,
Meng XJ: Use of a swine bioassay and a RT-PCR assay to assess
the risk of transmission of swine hepatitis E virus in pigs.  J
Virol Methods 2002, 101:71-78.
28. Li X, Kamili S, Krawczynski K: Quantitative detection of hepati-
tis E virus RNA and dynamics of viral replication in experi-
mental infection.  J Viral Hepat 2006, 13:835-839.
29. Kasorndorkbua C, Guenette DK, Huang FF, Thomas PJ, Meng XJ, Hal-
bur PG: Routes of transmission of swine hepatitis E virus in
pigs.  J Clin Microbiol 2004, 42:5047-5052.
30. Lee YH, Ha Y, Ahn KK, Chae C: Localisation of swine hepatitis E
virus in experimentally infected pigs.  Vet J 2009, 179:417-421.
31. Kasorndorkbua C, Thacker BJ, Halbur PG, Guenette DK, Buitenwef
RM, Royer RL, Meng XJ: Experimental infection of pregnant
gilts with swine hepatitis E virus.  Can J Vet Res 2003, 67:303-306.
32. Halbur PG, Kasorndorkbua C, Gilbert C, Guenette D, Potters MB,
Purcell RH: Comparative pathogenesis of infection of pigs
with hepatitis E viruses recovered from a pig and a human.  J
Clin Microbiol 2001, 39:918-923.
33. Williams TPE, Kasorndorkbua C, Halbur PG, Haqshenas G, Guenette
DK, Toth TE, Meng XJ: Evidence of extrahepatic site of replica-
tion of the hepatitis E virus in a swine model.  J Clin Microbiol
2001, 39:3040-3046.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2334/9/93/prepub